Related references
Note: Only part of the references are listed.The emerging roles of IFIT3 in antiviral innate immunity and cellular biology
Wentao Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2023)
Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Xiaohui Suo et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)
Different mechanisms of drug resistance to hypomethylating agents in the treatment of myelodysplastic syndromes and acute myeloid leukemia
Kristina Simonicova et al.
DRUG RESISTANCE UPDATES (2022)
Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?
Saravanan Ganesan et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma
Yuxiong Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
Kongfei Li et al.
Aging-US (2021)
Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer
Xing Fei Tan et al.
CURRENT MEDICINAL CHEMISTRY (2021)
The Role of Tumor-Associated Macrophages in Leukemia
Yueyang Li et al.
ACTA HAEMATOLOGICA (2020)
The Association of Circulating T Follicular Helper Cells and Regulatory Cells with Acute Myeloid Leukemia Patients
Zhenxing Guo et al.
ACTA HAEMATOLOGICA (2020)
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Andrew H. Wei et al.
BLOOD (2020)
Immune escape and immunotherapy of acute myeloid leukemia
Luca Vago et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Expression patterns of immune checkpoints in acute myeloid leukemia
Cunte Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression
Jun Huang et al.
CELL DEATH & DISEASE (2019)
Toward understanding the origin and evolution of cellular organisms
Minoru Kanehisa
PROTEIN SCIENCE (2019)
IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling
Vijaya Kumar Pidugu et al.
ONCOGENE (2019)
Emerging Functions of Human IFIT Proteins in Cancer
Vijaya Kumar Pidugu et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2019)
Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients
Lujun Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network
H. Jia et al.
ONCOGENE (2017)
Hepatic IFIT3 Predicts Interferon-α Therapeutic Response in Patients of Hepatocellular Carcinoma
Yingyun Yang et al.
HEPATOLOGY (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker et al.
NATURE REVIEWS CANCER (2016)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Toward Individualized Therapy in Acute Myeloid Leukemia A Contemporary Review
Tapan M. Kadia et al.
JAMA ONCOLOGY (2015)
Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular pseudoinflammation contributing to an aggressive phenotype
Hanno Niess et al.
ONCOTARGET (2015)
MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
Xiaoshan Feng et al.
BMC CANCER (2014)
Association of Interferon-induced protein with tetratricopeptide repeats 1 and 3 expression with regional metastasis and drug resistance in oral squamous cell carcinoma
Ai-Hsin Yen et al.
CANCER RESEARCH (2014)
Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
Yixiang Han et al.
CANCER SCIENCE (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Structural basis for viral 5′-PPP-RNA recognition by human IFIT proteins
Yazan M. Abbas et al.
NATURE (2013)
Protective Roles of Interferon-Induced Protein with Tetratricopeptide Repeats 3 (IFIT3) in Dengue Virus Infection of Human Lung Epithelial Cells
Yu-Lin Hsu et al.
PLOS ONE (2013)
Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
Veronika Rockova et al.
BLOOD (2011)
The Interferon Stimulated Gene 54 Promotes Apoptosis
Marcin Stawowczyk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The ISG56/IFIT1 Gene Family
Volker Fensterl et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
AlgK Is a TPR-Containing Protein and the Periplasmic Component of a Novel Exopolysaccharide Secretin
Carrie-Lynn Keiski et al.
STRUCTURE (2010)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Ligand binding by TPR domains
AL Cortajarena et al.
PROTEIN SCIENCE (2006)
Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity
KJ Hope et al.
NATURE IMMUNOLOGY (2004)
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
L Thyrell et al.
ONCOGENE (2002)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
